SU429813A1 - METHOD OF TREATING PULMONARY TUBERCULOSIS - Google Patents

METHOD OF TREATING PULMONARY TUBERCULOSIS

Info

Publication number
SU429813A1
SU429813A1 SU1684551A SU1684551A SU429813A1 SU 429813 A1 SU429813 A1 SU 429813A1 SU 1684551 A SU1684551 A SU 1684551A SU 1684551 A SU1684551 A SU 1684551A SU 429813 A1 SU429813 A1 SU 429813A1
Authority
SU
USSR - Soviet Union
Prior art keywords
pulmonary tuberculosis
treating pulmonary
tuberculosis
treating
patients
Prior art date
Application number
SU1684551A
Other languages
Russian (ru)
Inventor
Г. И. Вавилнн Е. И. жецка М. Д. Круганов изобретени Е. П. Буторин
А. Г. Таланова Л. Н. Эртевциан Г. М. Маковска В. Е. Рыженков
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to SU1684551A priority Critical patent/SU429813A1/en
Application granted granted Critical
Publication of SU429813A1 publication Critical patent/SU429813A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

II

Изобретение относитс  к области медицины .This invention relates to the field of medicine.

Известно применение дл  лечени  туберкулеза легких туберкулостатических средств.It is known to treat pulmonary tuberculosis in treating tuberculosis.

Цель изобретени  - лечение больных с норэргической и пониженной реактивностью организма.The purpose of the invention is the treatment of patients with norergic and reduced reactivity of the organism.

Дл  этого одновременно с туберкулостатическими средствами примен ют этимизол.To do this, simultaneously with tuberculostatic agents, etizol is used.

Способ лечени  больных туберкулезоим осуществл ют следующим образом.The method for treating patients with tuberculosis is as follows.

Одновременно с туберкулостатическими препаратами примен ют 1,57о-пый раствор этимизола в суточных дозах 60-80 мг из расчета 1 мк/кг веса больного. Препарат ввод т внутримышечно по 1-2 мл в две-три инъекции . Кроме внутримышечного введени , возможно также подкожное и внутривенное введение .препарата, а также пероральное в виде таблеток. У подростков по сравнению со взрослыми примен ют меньшие дозы - не более 3 мл 1,5%-ного препарата в двух-трехSimultaneously with tuberculostatic drugs, a 1.57% solution of aetizol is used in daily doses of 60-80 mg at a rate of 1 micron / kg of patient weight. The drug is administered intramuscularly in a dose of 1-2 ml in two or three injections. In addition to intramuscular administration, subcutaneous and intravenous administration of the preparation is also possible, as well as oral administration in the form of tablets. In adolescents, compared with adults, smaller doses are used - no more than 3 ml of 1.5% drug in two or three

инъекци х. Курс лечени  этимизолом продолжают 30-50 дпей и в случае необходимости повтор ют после двух-четырехнедельного интервала .injections. The treatment with etizol is continued at 30-50 dpi and, if necessary, is repeated after a two to four week interval.

Применение этимизола в комплексной терапии больных туберкулезом существенно повышает эффективность лечени . При этом достигаетс  быстра  дези-нтоксикаци , абацилирование , инволюци  воспалительных изменений в короткие сроки, снижение аллергической настроенности организма улучшение переносимости химпрепаратов.The use of ethymol in the complex therapy of patients with tuberculosis significantly increases the effectiveness of treatment. At the same time, quick detoxification, abacilization, involution of inflammatory changes in a short time, reduction of the body's allergic mood, improvement of tolerability of chemicals are achieved.

Предмет изобретени Subject invention

Способ лечени  туберкулеза легких с помощью туберкулостатических средств, отличающийс  тем, что, с целью лечени  больных с норэргической и понижепной реактивностью организма, одновременно с туберкулостатическими средствами примен ют этимизол .A method of treating pulmonary tuberculosis using tuberculostatic agents, characterized in that, in order to treat patients with norergic and lower body reactivity, etizol is used simultaneously with tuberculostatic agents.

SU1684551A 1971-08-20 1971-08-20 METHOD OF TREATING PULMONARY TUBERCULOSIS SU429813A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU1684551A SU429813A1 (en) 1971-08-20 1971-08-20 METHOD OF TREATING PULMONARY TUBERCULOSIS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU1684551A SU429813A1 (en) 1971-08-20 1971-08-20 METHOD OF TREATING PULMONARY TUBERCULOSIS

Publications (1)

Publication Number Publication Date
SU429813A1 true SU429813A1 (en) 1974-05-30

Family

ID=20483930

Family Applications (1)

Application Number Title Priority Date Filing Date
SU1684551A SU429813A1 (en) 1971-08-20 1971-08-20 METHOD OF TREATING PULMONARY TUBERCULOSIS

Country Status (1)

Country Link
SU (1) SU429813A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422350A (en) * 1992-09-10 1995-06-06 Warner-Lambert Company Nitrogen substituted acridine and cytochrome P450 inhibitors and methods of use
US5466696A (en) * 1992-09-10 1995-11-14 Warner Lambert Company Tacrine and cytochrome P450 oxidase inhibitors and methods of use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422350A (en) * 1992-09-10 1995-06-06 Warner-Lambert Company Nitrogen substituted acridine and cytochrome P450 inhibitors and methods of use
US5466696A (en) * 1992-09-10 1995-11-14 Warner Lambert Company Tacrine and cytochrome P450 oxidase inhibitors and methods of use

Similar Documents

Publication Publication Date Title
RU95101385A (en) Products containing g-csf and tnf-binding protein
Bush Prolonged neuromuscular block due to intraperitoneal streptomycin
KR910005858A (en) Fatty acid therapy
SU429813A1 (en) METHOD OF TREATING PULMONARY TUBERCULOSIS
MY106603A (en) Treatment of genital warts with a combination of liquid nitrogen and recombinant dna human alpha interferon
Verrill et al. Vasovagal faint in the supine position.
Redpath et al. The side effects of carbamazepine therapy
KR20000005479A (en) New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
RU95112520A (en) APPLICATION 4'-IODO-4'-DEOXIDOXORUBICINE FOR THE TREATMENT OF AMYLOIDOSIS, METHOD OF TREATMENT OF AMYLOIDOSIS
RU1803119C (en) Method of extrauterine pregnancy treatment
Gjessing et al. Intramuscular injection of procaine penicillin combined with oral administration of ampicillin in the treatment of gonorrhoea
SU624635A1 (en) Method of treating chronic calculus-free pancreatitis
SU1725902A1 (en) Method of children treatment with chronic tonsillitis
Furman et al. Use of Cholinergic Drugs in Paroxysmal Supraventricular Tachycardia: Serious Untoward Reactions and Fatality from Treatment with Methacholine and Neostigmine
Mukerji et al. The treatment of intestinal worms with the indigenous drugs Butea, Embelia and kamala
SU1391654A1 (en) Method of treatment of chronic gastroduodenits
RU2140270C1 (en) Method of treatment of patient with kaposi's sarcoma idiopathic type
SU1255134A1 (en) Method of treatment of pain syndrome in myocardial infarction
RU2233664C2 (en) Method for treatment of lichen ruber planus
Waxman Management of depression.
Gilles et al. Treatment of intestinal parasites in children
RU2099061C1 (en) Method for treating the cases of neurodermite
RU2071342C1 (en) Method of treatment of cirrhotic form of lung tuberculosis
SU1034741A1 (en) Tuberculosis treatment method
RU2108799C1 (en) Method of treatment of nodular erythema